Sci. Aging Knowl. Environ., 14 November 2001
Vol. 2001, Issue 7, p. or22

OTHER RESOURCES

Kinetic Stabilization of the {alpha}-Synuclein Protofibril by a Dopamine-{alpha}-Synuclein Adduct

Kelly A. Conway, Jean-Christophe Rochet, Robert M. Bieganski, and Peter T. Lansbury Jr.

http://sageke.sciencemag.org/cgi/content/abstract/sageke;2001/7/or22

Abstract: Science 294, 1346 (2001).

The substantia nigra in Parkinson's disease (PD) is depleted of dopaminergic neurons and contains fibrillar Lewy bodies comprising primarily {alpha}-synuclein. We screened a library to identify drug-like molecules to probe the relation between neurodegeneration and {alpha}-synuclein fibrilization. All but one of 15 fibril inhibitors were catecholamines related to dopamine. The inhibitory activity of dopamine depended on its oxidative ligation to {alpha}-synuclein and was selective for the protofibril-to-fibril conversion, causing accumulation of the {alpha}-synuclein protofibril. Adduct formation provides an explanation for the dopaminergic selectivity of {alpha}-synuclein-associated neurotoxicity in PD and has implications for current and future PD therapeutic and diagnostic strategies.

Full Text








Science of Aging Knowledge Environment. ISSN 1539-6150